ctrl K

Price Alert

Kezar Life Sciences Inc. (KZR)

NASDAQ: KZR · Real-Time Price · USD

3.97

-0.01 (-0.25%)

At close: Aug 15, 2025, 3:59 PM

4.07

2.52%

After-hours: Aug 15, 2025, 07:48 PM EDT

Kezar Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	41.75M	35.49M	40.46M	62.88M
Short-Term Investments	90.5M	165.88M	236.1M	145.47M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.42M	5.59M	674K	282K
Receivables	424K	2.29M	n/a	70K
Inventory	n/a	n/a	n/a	2.5M
Other Current Assets	351K	251K	920K	-1.84M
Total Current Assets	137.49M	206.95M	285.72M	211.65M
Property-Plant & Equipment	4.78M	8.69M	13.17M	6M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.19M	14.29M	13.85M	6.28M
Total Assets	144.68M	221.24M	299.57M	217.93M
Account Payables	3.65M	8.25M	2.48M	2.03M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	5.22M	3.01M	2.56M	1.2M
Other Current Liabilities	5.22M	802K	960K	1.82M
Total Current Liabilities	20.33M	17.74M	11M	8.21M
Long-Term Debt	5.11M	10.07M	9.83M	9.62M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	7.44M	15.92M	18.7M	12.85M
Total Liabilities	27.77M	33.66M	29.7M	21.06M
Total Debt	16.18M	18.93M	21.26M	14.04M
Common Stock	7K	73K	68K	56K
Retained Earnings	-434.5M	-350.76M	-248.89M	-180.65M
Comprehensive Income	-162K	-130K	-923K	-291K
Shareholders Equity	116.92M	187.57M	269.87M	196.88M
Total Investments	90.5M	165.88M	236.1M	145.47M